209 results match your criteria: "Optic Neuritis Childhood"

Characteristics and predictors of disease course in children initially presenting with ADEM.

Mult Scler Relat Disord

October 2023

UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, United States.

ADEM is an inflammatory disease, with new onset polyfocal neurologic symptoms, encephalopathy and multifocal demyelination, typically in childhood. Initial diagnosis of ADEM is challenging and up to 20 % of children with MS or NMOSD are initially diagnosed with ADEM. We describe characteristics of patients with monophasic ADEM vs.

View Article and Find Full Text PDF

Rhinosinusitis is a common childhood illness that may result in a number of ocular problems. The goal of this thorough analysis is to compile the available data regarding the kinds, prevalence, and treatment of ocular problems related to juvenile rhinosinusitis. A comprehensive analysis of electronic databases, such as PubMed, Embase, and Cochrane Library, was carried out to pinpoint pertinent research articles written in English and published between the beginning and August of 2023.

View Article and Find Full Text PDF

Racial, Ethnic, and Socioeconomic Disparities in Pediatric Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Pediatr Neurol

December 2024

Division of Neurology, Department of Pediatrics, Children's of Alabama, Birmingham, Alabama.

Background: Only 5% of aquaporin-4-positive neuromyelitis optica spectrum disorder (AQP4+ NMOSD) cases emerge during childhood. Poorer outcomes have been suggested in black/African American (AA) adults with NMOSD; however, conflicting and limited data exist for pediatric-onset NMOSD. This study evaluates racial, ethnic, and socioeconomic disparities in pediatric AQP4+ NMOSD outcomes.

View Article and Find Full Text PDF

[Leber's hereditary optic neuropathy].

Rinsho Shinkeigaku

May 2024

Department of Orthoptics and Visual Science, School of Allied Health Sciences, Kitazato University.

Article Synopsis
  • Leber's hereditary optic atrophy (LHON) is a genetic condition primarily affecting young males, caused by mutations in mitochondrial DNA that disrupt the electron transport chain, leading to vision loss.
  • The condition typically starts with vision impairment in one eye, quickly progressing to the other eye, resulting in very low visual acuity for many patients.
  • Differentiating LHON from other causes of optic neuritis involves various assessments, and collaboration between neurologists and ophthalmologists is vital for proper diagnosis and treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Area Postrema Syndrome (APS) is a rare childhood condition characterized by severe nausea and hiccups, often related to serious diseases like neuromyelitis optica spectrum disorders (NMOSD) and brainstem glioma.
  • The study analyzed two unrelated Japanese cases of APS to assess the causes and outcomes, including detailed radiological and autoantibody examinations.
  • Results showed that the 14-year-old with NMOSD improved with treatment, while the 9-year-old with a glioma faced long-term persistent symptoms, indicating varying prognoses based on age and underlying conditions.
View Article and Find Full Text PDF

Early life stress aggravates disease pathogenesis in mice with experimental autoimmune encephalomyelitis: Support for a two-hit hypothesis of multiple sclerosis etiology.

J Neuroimmunol

December 2023

Canadian Centre for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, Alberta T1K 3M4, Canada; Southern Alberta Genome Sciences Centre, University of Lethbridge, Lethbridge, Alberta T1K 3M4, Canada. Electronic address:

Vision problems are one of the earliest diagnosed symptoms of multiple sclerosis (MS). The onset and progression of vision loss and the underlying pathogenesis in MS may be influenced by cumulative psychophysiological stress. Here, we used a two-hit model of stress in female mice to determine if early life stress (ELS, the first hit) influences the response to an immunization that induces experimental autoimmune encephalomyelitis (EAE, the second hit) later in life.

View Article and Find Full Text PDF

M-DDC: MRI based demyelinative diseases classification with U-Net segmentation and convolutional network.

Neural Netw

January 2024

Machine Learning and I-health International Cooperation Base of Zhejiang Province, Hangzhou Dianzi University, 310018, China; Artificial Intelligence Institute, Hangzhou Dianzi University, Zhejiang, 310018, China. Electronic address:

Childhood demyelinative diseases classification (DDC) with brain magnetic resonance imaging (MRI) is crucial to clinical diagnosis. But few attentions have been paid to DDC in the past. How to accurately differentiate pediatric-onset neuromyelitis optica spectrum disorder (NMOSD) from acute disseminated encephalomyelitis (ADEM) based on MRI is challenging in DDC.

View Article and Find Full Text PDF

The occurrence of combined central and peripheral demyelination (CCPD) is rare, data are limited to small case and cohort studies, mainly concerning adults. In few patients positivity to anti MOG antibody is reported, thus widening the spectrum of anti-MOG associated disorders (MOGAD). We describe a 7-year-old girl with optic neuritis followed 8 years later by peripheral demyelination, with fluctuating anti-MOG antibody positivity at cell-based assay.

View Article and Find Full Text PDF

An update on optic neuritis.

J Neurol

October 2023

Department of Ophthalmology, Mayo Clinic Hospital, Rochester, MN, USA.

Article Synopsis
  • * Differentiating between typical and atypical ON is crucial as they have distinct prognoses and treatments; atypical ON often presents with severe symptoms and requires specific serological testing for AQP4-IgG and MOG-IgG.
  • * While typical ON usually recovers well with or without treatment, atypical ON often needs aggressive therapies like intravenous steroids, plasma exchange, or immunosuppress
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on detecting myelin oligodendrocyte glycoprotein autoantibodies (MOG-Ab), crucial for diagnosing MOG-Ab-associated disease (MOGAD), and explored the clinical implications of different recognized epitopes.
  • Researchers created a cell-based immunoassay to identify MOG-Ab epitopes and conducted a retrospective review of 55 patients in a registry, evaluating their serum samples.
  • Key findings revealed that the P42 epitope in MOG is a significant target for MOG-Ab, primarily associated with monophasic disease and childhood onset in affected patients, highlighting the need for further research on MOG-Ab's predictive value and epitopes.
View Article and Find Full Text PDF

Deviation From Normative Whole Brain and Deep Gray Matter Growth in Children With MOGAD, MS, and Monophasic Seronegative Demyelination.

Neurology

July 2023

From the Department of Medicine (G.F), University of Ottawa, Ottawa Hospital Research Institute; Montreal Neurological Institute (A.C.P., S.N., D.L.A., D.L.C.), McGill University, Quebec; Department of Community Health Sciences (J.O.M., R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Nuffield Department of Clinical Neurosciences (P.W.), John Radcliffe Hospital, University of Oxford, United Kingdom; Department of Pediatrics (E.A.Y.), University of Toronto, Ontario, Canada; Center for Neuroinflammation and Neurotherapeutics (A.B.-O.), and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia; Department of Internal Medicine (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; and Division of Child Neurology (B.B.), Department of Neurology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania.

Article Synopsis
  • The study investigates how pediatric MOG antibody-associated disease (MOGAD) affects brain growth in children compared to healthy peers and those with MS or monophasic demyelination, highlighting the possible impact on brain maturation.* -
  • Researchers included children diagnosed with MOGAD, MS, or monophasic demyelination from a longitudinal study and used brain MRI scans to analyze regional brain volumes against normative data from healthy children.* -
  • Findings revealed that children with MOGAD show significant delays in expected brain growth, particularly in areas like the thalamus and caudate, indicating a deviation from typical brain development patterns.*
View Article and Find Full Text PDF

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents.

Arq Neuropsiquiatr

February 2023

Pontifícia Universidade Católica do Rio Grande do Sul, Instituto do Cérebro do Rio Grande do Sul, Porto Alegre RS, Brazil.

Article Synopsis
  • * Children and adolescents who develop NMOSD exhibit similar symptoms and diagnostic criteria as adults, but research on pediatric cases is limited.
  • * New treatments for AQP4-IgG-positive NMOSD have been approved for adults, with only one drug (satralizumab) tested in adolescents, highlighting the need for further clinical trials specifically for children with NMOSD.
View Article and Find Full Text PDF
Article Synopsis
  • Optic neuritis (ON) often signals the onset of multiple sclerosis (MS) and other related disorders, with high-dose corticosteroids recommended for treatment but not adequately studied regarding timing and patient antibodies.
  • The Acute Optic Neuritis Network (ACON) aims to investigate how the timing of corticosteroid treatment affects visual outcomes 6 months post-ON onset by enrolling patients who present within 30 days of initial symptoms.
  • The study will collect extensive data on various ON subtypes and factors like visual acuity, imaging results, and patient-reported outcomes from 28 hospitals globally, targeting a recruitment of 200 patients across different ON classifications.
View Article and Find Full Text PDF

Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD.

Neurol Neuroimmunol Neuroinflamm

January 2023

From the Paediatric Neurology and Neurophysiology Unit (M.N., I.T., Stefano Sartori), Department of Women's and Children's Health, University Hospital of Padova, Italy; Neuroimmunology Group (M.N., L.Z., Stefano Sartori), Paediatric Research Institute "Città della Speranza," Padova, Italy; School of Biomedical Engineering and Imaging Sciences (M.E.), King's College London, United Kingdom; Children's Neurosciences, Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Unit of Child Neuropsychiatry (Thea Giacomini, R.C., M.M.M.), Clinical and Surgical Neurosciences Department, IRCCS Giannina Gaslini Institute, Genoa, Genoa, Liguria, Italy; Neuroscience Department (M.V., L.P., M.A.N.F.), Bambino Gesù Children's Hospital IRCCS, Rome, Italy; Department of Neurosciences (M.D.C., Antonio Varone), Pediatric Neurology, Santobono-Pausilipon Children's Hospital, Naples, Italy; Unit of Rare Diseases of the Nervous System in Childhood (A.D.P.), Department of Clinical and Experimental Medicine, University of Catania, Italy; Multiple Sclerosis Center (P.A.), ASST della Valle Olona, Hospital of Gallarate, Italy; Child Neurology and Psychiatry Unit (D.M.C., A.F.), Department of Medical and Surgical Sciences (DIMEC), SOrsola Hospital, University of Bologna, Italy; Division of Pediatrics (Giovanni Crichiutti, V.D.), Department of Medicine, University Hospital of Udine, Italy; Unit of Child Neurology and Psychiatry (G.D.R.), Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi," University of Messina, Italy; Department of Pediatric Neuroscience (E.F., T.G.., N.N., F.R., A.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; GALLO Multiple Sclerosis Centre (P.G., M.M., M.P.), Neurology Clinic, Department of Neuroscience, Università degli Studi di Padova, Italy; Neuroimmunology Laboratory (M.G.), IRCCS Mondino Foundation, Pavia, Italy; Unit of Pediatrics (L.G., C.P.), ULSS 2 Marca Trevigiana, Ca' Foncello Hospital, Treviso, Italy; Institute of Neurology (R.I.), Fondazione Policlinico Universitario "AGemelli" IRCCS, Rome, Italy; Child Neurology Unit and Laboratories (M.L., F.M.), Neuroscience Department, Meyer Children's University Hospital, Florence, Italy; Neurology Unit (Sara Mariotto), Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, Policlinico GB Rossi, Italy; Child Neurology and Psychiatry Unit (Sara Matricardi, Sabrina Siliquini), "GSalesi" Children's Hospital, Ospedali Riuniti Ancona, Italy; Child Neuropsychiatry Unit (A.P.), ASST Grande Ospedale Metropolitano Niguarda, Milano; Child Neuropsychiatry Unit (F.P., E.C.T.), Department of Medicine and Surgery, University of Parma, Italy; Pediatric Clinic (Salvatore Savasta, T.F.), Fondazione IRCCS Policlinico San Matteo, University of Pavia, Italy; Clinical Neurology (Alberto Vogrig), Azienda Ospedaliero Universitaria Friuli Centrale, Udine, Italy; Department of Neurology (L.Z.), Ospedale San Bortolo, Vicenza, Italy; U.O.CPediatria (S.B., S.R.), Ospedale San Bortolo, Vicenza, Italy; Pediatric Neurology (A.O.), Pediatric University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Italy; Child Neuropsychiatry (Gaetano Cantalupo), Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona, Italy; and Department of Neuroscience (Stefano Sartori), University of Padova, Italy.

Article Synopsis
  • The study aimed to identify early indicators of relapse and outcomes in pediatric patients with myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD).* -
  • Researchers analyzed data from 75 children, finding differences in disease presentation based on age; younger patients were more likely to present with acute disseminated encephalomyelitis, while older patients saw more cases of optic neuritis.* -
  • Results highlighted specific early treatment factors, such as starting immunotherapy within 7 days or prolonged corticosteroid use, as associated with lower relapse risks; 21.1% of patients had moderate to severe disability at final follow-up, particularly among those with relapsing disease.*
View Article and Find Full Text PDF

Evolution of clinically isolated syndrome to pediatric-onset multiple sclerosis and a review of the literature.

Turk J Med Sci

August 2022

Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Background: Clinically isolated syndrome (CIS) may be the first presentation of pediatric onset multiple sclerosis (POMS). We retrospectively evaluated the clinical and laboratory data of pediatric CIS (pCIS) patients who were diagnosed with POMS upon followup for any predictive variables. We also reviewed the literature concerning the management of pCIS.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the effectiveness of mycophenolate mofetil (MMF) in treating childhood MOG-IgG-associated disorder (MOGAD) in 30 patients who had been on the medication for over a year.
  • About 66.67% of these patients did not face any relapses during MMF therapy, and there was a significant decrease in annualized relapse rate (ARR) while on the medication.
  • The findings concluded that MMF is both safe and effective for childhood MOGAD, but no specific clinical characteristics were identified that could predict how well it would work for individual patients.
View Article and Find Full Text PDF

Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease (CTD), the main features of which are multiple serum autoantibodies and extensive involvement of multiple systems. The onset age of patients varies from childhood to middle age, with nearly 1/5 in childhood. Sjogren's syndrome (SS) is also an autoimmune disease characterized by high-degree lymphocytic infiltration of exocrine glands, usually occurring in middle-aged and older women, and rarely in childhood.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory demyelinating diseases affecting the central nervous system in children include conditions like ADEM, MS, NMOSD, and MOGAD, which can be hard to differentiate and may go undiagnosed for a long time.
  • Researchers evaluated biomarkers, particularly focusing on urinary neopterin and its levels in pediatric MS compared to other groups, finding that pMS patients had significantly higher urinary neopterin concentrations.
  • A specific urinary neopterin level (>167.75 µmol/mol creatinine) could effectively distinguish pediatric MS patients from healthy controls, showing a good sensitivity of 71% and specificity of 90%.
View Article and Find Full Text PDF

Background And Purpose: Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are detected at a high rate in childhood of acquired demyelinating syndrome (ADS), but the spectrum and characteristics of MOG-Abs-associated disorders (MOGAD) in children are to be determined. This study aimed to identify clinical features in Chinese children with MOGAD.

Methods: Of 48 children in whom MOGAD were diagnosed in our hospital, we analyzed the manifestations, laboratory test results, imaging characteristics, autoimmune antibodies in cerebrospinal fluid and serum, and response to treatment.

View Article and Find Full Text PDF

Background: Childhood neuromyelitis optica spectrum disorders (NMOSDs) may cause visual impairment and brain or spinal cord damage, and the effects may be permanent if left untreated. Since the incidence of NMOSD cases in children is relatively low, the understanding of NMOSD among children is inadequate.

Methods: This investigation examined the clinical and neuroimaging characteristics of childhood NMOSD.

View Article and Find Full Text PDF

Aim: To describe a 10-year follow-up of children (<16y) with acquired demyelinating syndromes (ADS) from a UK-wide prospective surveillance study.

Method: Diagnoses were retrieved from the patients' records via the patients' paediatric or adult neurologist using a questionnaire. Demyelinating phenotypes at follow-up were classified by an expert review panel.

View Article and Find Full Text PDF

Refractory hyponatremia in neuromyelitis optica in a pediatric patient: A case report.

Medicine (Baltimore)

July 2021

Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, No.325, Section 2, Chenggong Rd., Neihu District, Taipei, Taiwan.

Rationale: Neuromyelitis optica spectrum disorders (NMOSD) is a rare autoimmune disease predominantly involving optic nerves and spinal cord, and possible comorbidities including syndrome of inappropriate antidiuretic hormone secretion or urinary complication. We reported a young girl diagnosed with NMOSD presented with refractory hyponatremia, acute urine retention, and general weakness. Clinical symptoms improved gradually after receiving intravenous immunoglobulin, high-dose methylprednisolone, and plasmapheresis.

View Article and Find Full Text PDF

Background: To evaluate the demographic, etiological, and clinical properties, as well as the treatment modalities of neuro-ophthalmological diseases in childhood.

Methods: We retrospectively analyzed the clinical data of patients younger than 18 years old who were referred to the Neuro-Ophthalmology Department of Ulucanlar Eye Hospital from 2004 to 2019.

Results: Of 1,910 patients who presented to the Neuro-Ophthalmology Department, 128 (6.

View Article and Find Full Text PDF

There are several important relapsing demyelinating syndromes (RDS) that may present in childhood, of which paediatric-onset multiple sclerosis is the most common. These are rare conditions, so recognising presentations and referring early to specialist services is important to enable prompt diagnosis and effective treatment. Understanding of RDS is rapidly evolving, with many new and effective treatments that aim to reduce relapses and disability accumulation.

View Article and Find Full Text PDF

To evaluate the clinical and neuroimaging features of pediatric acquired demyelinating syndromes (ADS) in a tertiary pediatric neurology clinic in Turkey. All children diagnosed with any subset of ADS between 2013 and 2018 were included in this retrospective cohort study. Forty-two patients (21 female) with a median follow-up period of 30 months were included.

View Article and Find Full Text PDF